| Entry |
|
|---|
| Name |
Carmofur (JP18/INN);
Mifurol (TN) |
|---|
| Formula |
C11H16FN3O3
|
|---|
| Exact mass |
257.1176
|
|---|
| Mol weight |
257.2614
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Antimetabolite |
|---|
| Comment |
Active form of prodrug: Fluorouracil [DR: D00584]
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Other map |
| map00983 | Drug metabolism - other enzymes |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BC Pyrimidine analogues
L01BC04 Carmofur
D01784 Carmofur (JP18/INN)
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01935 Fluoropyrimidine antineoplastic
D01784 Carmofur
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Methyltransferases
TYMS
D01784 Carmofur (JP18/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01784 Carmofur
Prodrugs [br08324.html]
D01784
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 18
1 C8x C 16.7300 -9.2400
2 N4y N 16.7300 -10.6400
3 C8y C 17.9424 -11.3400
4 N4x N 19.1549 -10.6400
5 C8y C 19.1549 -9.2400
6 C8y C 17.9424 -8.5400
7 O5x O 20.3860 -8.5290
8 O5x O 17.9424 -12.7398
9 C5a C 15.5176 -11.3400
10 N1b N 14.3051 -10.6400
11 C1b C 13.0927 -11.3400
12 C1b C 11.8803 -10.6400
13 C1b C 10.6678 -11.3400
14 C1b C 9.4554 -10.6400
15 C1b C 8.2430 -11.3400
16 O5a O 15.5176 -12.7398
17 X F 17.9424 -7.1402
18 C1a C 7.0434 -10.6473
BOND 18
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 2
7 5 7 2
8 3 8 2
9 2 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 9 16 2
17 6 17 1
18 15 18 1
|
|---|
